ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
9,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
9,3,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
9,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
10,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
10,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
10,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
11,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
12,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
13,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
14,1,Budd-Chiari syndrome,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
15,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
16,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
17,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
18,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
19,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
20,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
21,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
21,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
23,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
24,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
25,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
25,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
26,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
26,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
27,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
28,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
28,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
29,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
29,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
30,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
31,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
33,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
33,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
33,3,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
34,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
34,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
35,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
36,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
37,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
38,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
38,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
38,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
39,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
39,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
39,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
40,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
41,1,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
42,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
42,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
43,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
43,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
44,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
44,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
46,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
47,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
47,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
47,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
47,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
48,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
49,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
49,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
49,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
50,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
51,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
52,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
52,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
52,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
52,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
52,5,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
52,6,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
53,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
54,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
54,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
55,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
56,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
56,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
57,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
58,1,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
59,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
59,2,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
59,3,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
60,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
61,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
62,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
62,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
62,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
62,4,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
63,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
63,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
64,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
65,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
66,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
66,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
67,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
68,1,Migraine,Migraine headaches,Headaches,Nerv,N
69,1,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
70,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
71,1,Congenital hand malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
71,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
72,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
72,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
73,1,Follicular thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
74,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
74,2,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
75,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
75,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
76,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
77,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
78,1,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
79,1,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
80,1,Diffuse large B-cell lymphoma stage IV,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
81,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
81,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
81,3,Migraine,Migraine headaches,Headaches,Nerv,N
81,4,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
82,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
83,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
84,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
84,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
85,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
86,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
87,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
88,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
89,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
90,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
90,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
90,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
90,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
90,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
91,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
91,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
91,3,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
92,1,Axillary vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
92,2,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
93,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
93,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
93,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
94,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
95,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
95,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
95,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
96,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
96,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
96,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
96,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
96,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
96,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
96,7,Fungating wound,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
96,8,Micturition frequency decreased,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
96,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
96,10,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
96,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
96,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
97,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
97,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
97,3,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
97,4,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
97,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
98,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
98,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
98,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
98,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
98,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
98,6,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
98,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
98,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
99,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
99,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
99,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
100,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
100,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
101,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
101,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
101,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
102,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
103,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
104,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,2,Hodgkin's disease lymphocyte predominance type refractory,Hodgkin's disease lymphocyte predominance type,Lymphomas Hodgkin's disease,Neopl,N
105,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,2,Hodgkin's disease lymphocyte predominance type refractory,Hodgkin's disease lymphocyte predominance type,Lymphomas Hodgkin's disease,Neopl,N
106,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
106,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
108,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
108,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
108,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
108,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
109,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
110,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
111,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
111,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
111,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
111,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
111,5,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
111,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
112,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
113,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
114,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
114,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
114,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
114,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
115,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
116,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
116,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
116,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
117,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
118,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
118,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
118,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
118,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
119,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
120,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
120,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
121,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
121,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
121,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
121,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
122,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
122,2,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
122,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
123,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
123,2,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
124,1,Leiomyosarcoma metastatic,Leiomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
124,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
124,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
125,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
125,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
126,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
126,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
126,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
127,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
128,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
128,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
128,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
128,4,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
128,5,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
129,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
129,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
129,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
129,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
129,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
130,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
130,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
130,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
130,4,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
130,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
130,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
130,7,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
130,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
131,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
131,2,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
131,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
132,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
132,2,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
132,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
132,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
133,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
134,1,Administration site reaction,Administration site reactions NEC,Administration site reactions,Genrl,N
134,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
135,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
135,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
136,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
137,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
137,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
137,3,Intestinal stenosis,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
138,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
139,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
139,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
139,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
139,4,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
139,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
139,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
140,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
140,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
141,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
142,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
143,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
143,2,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
143,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
143,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
144,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
145,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
145,2,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
145,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
145,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
145,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
145,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
145,7,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
145,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
145,9,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
